NIH-funded research R01 grant

In-home HEPA filtration to slow biological aging and improve heart and lung health in older adults with eosinophilic COPD

Official title: Impact of an Air Purification Intervention on Biological Aging and Molecular Signatures of Improved Cardiometabolic Health in High-Risk Older Adults

Funded at Stanford University · NIH-11390736 · Data updated 2026-11-12

A 12-month in-home HEPA filter trial in older adults with eosinophilic COPD examines whether cleaner indoor air can slow aging markers and improve heart and lung health.

More Aging research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionStanford University
NIH-funded
Lab location1 site (Stanford, United States)
Project startAugust 13, 2026
Project endMay 31, 2031
Funding year2026
Award (this year)$850,689
NIH project number1R01ES038763-01
Project IDNIH-11390736 on NIH RePORTER

Who could benefit from this research

Could help

Older adults (21+ years) with eosinophilic COPD who smoke or have a history of smoking and live in homes where HEPA filtration could be implemented.

Less likely to help

Individuals without eosinophilic COPD or without environmental exposure to indoor particulates may not experience the same biological or clinical benefits.

What this research studies

This study builds on a randomized, double-blind trial that places HEPA filters or sham devices in homes of former smokers with eosinophilic COPD for one year. Researchers will measure aging-related molecular changes in nasal tissue and blood, along with cardiopulmonary health indicators, to see if cleaner air slows aging at a biological level. The approach combines epigenetic and proteomic analyses with clinical assessments to understand how reducing indoor particulate exposure affects aging and disease risk in a high-risk population. Participants will continue to receive follow-up visits and sample collection as part of the parent trial at NIEHS. Overall, the project seeks to link real-world air quality improvements to tangible biological and health benefits for older adults with COPD.

Why it matters

Potential benefit: If successful, participants could experience slower biological aging signals and improved heart and lung health from a simple air-cleaning intervention.

How similar studies have gone: Previous studies link air purification to reduced pollutant exposure; this study uniquely tests causal effects on molecular aging markers in a high-risk human population.

Where this research is happening

  • Stanford University
    Stanford, United States
    Active

Researchers

  • Principal investigator: Cardenas, Andres — Stanford University
  • Study coordinator: Cardenas, Andres

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.